{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-122450","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2022-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.141457+00:00","generated_at":"2026-06-21T12:43:58.473217+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"iSpecimen appoints Joseph J. Basile to board, replacing departing director Margaret H. Lawrence","bullets":["Margaret H. Lawrence resigned as director effective Nov 15, 2022; vacancy filled by Joseph J. Basile effective Nov 28, 2022.","Mr. Basile appointed to audit committee and nominating & corporate governance committee; independent director under Nasdaq rules.","Mr. Basile has extensive M&A experience; currently founder of Pari Passu M&A Mediation and Senior Advisor at Hogan Lovells.","No family relationships or transactions with the company; standard director indemnification agreement entered."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-122450","json":"https://secwatch.observer/filing/0001104659-22-122450.json","markdown":"https://secwatch.observer/filing/0001104659-22-122450.md","text":"https://secwatch.observer/filing/0001104659-22-122450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/0001104659-22-122450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/tm2231481d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:43:58.473217+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2600cc17d0","claim":"Margaret H. Lawrence resigned as Director at iSpecimen Inc..","evidence_excerpt":"Margaret H. Lawrence informed the Board of Directors (the “Board”) of the Company of her intention to resign as a director of the Company effective November 15, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/0001104659-22-122450-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ec890a9f84","claim":"Joseph J. Basile was appointed as Director at iSpecimen Inc..","evidence_excerpt":"approved the appointment of Joseph J. Basile to serve as a member of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/0001104659-22-122450-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}